Clinical Trials Directory

Trials / Completed

CompletedNCT06020612

Interobserver Variability Desmoplasia

Desmoplasia in Cutaneous Squamous Cell Carcinoma: Inter Observer Agreement Between Dermatopathologists.

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

According to the most recent guideline of the National Comprehensive Cancer Network (NCCN), desmoplasia is considered to be a very high risk factor for recurrence, metastasis and death in cutaneous squamous cell carcinoma (cSCC). The presence of desmoplasia is assessed by dermatopathologists during histological examination of cSCCs. However, the inter-observer agreement is between dermatopathologists in the assessment of desmoplasia is unclear. Studies on inter-observer variability in the assessment of differentiation grade in cSCCs showed that there is only a weak to moderate agreement among dermatopathologists in the assessment of differentiation grade (2-4). This study aims to investigate the interobserver agreement of desmoplasia between dermatopathologists. In this prospective study, 50 cSCCs will be assessed for desmoplasia by at least eight dermatopathologists using a predefined definition.

Conditions

Interventions

TypeNameDescription
OTHERAssessment by dermatopathologistsHistological assessment of the cSCCs by eight dermatopathologists.

Timeline

Start date
2023-07-01
Primary completion
2024-05-01
Completion
2024-06-01
First posted
2023-08-31
Last updated
2025-04-04

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06020612. Inclusion in this directory is not an endorsement.